兔模型中使用T2和T2* mapping评估早期蒽环类药物诱导的心脏毒性和肝损伤
研究纳入17只接受多柔比星每周注射的心脏毒性兔,每2周行MRI共10周,测量心功能及T2、T2*值,并行组织病理学检查。T2 mapping最早第2周检出早期蒽环类药物诱导的心脏毒性,集中于左心室第7、11、12节段;T2* mapping最早第6周检出室间隔中部铁含量变化和肝损伤,且室间隔中部T2*值与肝脏T2*值呈正相关。
要点
- T2 mapping最早于第2周检出早期蒽环类药物诱导的心脏毒性,集中于左心室第7、11、12节段。
- 左心室第7节段T2值截断值46.64诊断价值最佳,AUC为0.767,敏感度100%,特异度52%。
- T2* mapping最早第6周检出室间隔中部铁含量变化和肝损伤,室间隔中部T2*值与肝脏T2*值正相关(r=0.39,p=0.002)。
核心结论
- T2和T2* mapping对蒽环类药物诱导的心脏毒性和肝损伤具有一站式评估价值,可获得最早MRI诊断时间和最佳参数阈值。
研究设计与样本
- 研究纳入17只接受多柔比星每周注射的心脏毒性兔,每2周行MRI共10周,每次MRI后对2至5只兔行组织病理学检查。
关键影像表现/征象
- 早期蒽环类药物诱导的心脏毒性可最早于第2周由T2 mapping检出,集中于左心室第7、11、12节段。
- T2* mapping可最早于第6周检出室间隔中部早期心脏毒性的铁含量变化和肝损伤(p=0.014,p=0.027)。
- 室间隔中部T2*值与肝脏T2*值呈显著正相关(r=0.39,p=0.002)。
诊断标准与关键数值
- 左心室第7节段T2值截断值46.64诊断早期蒽环类药物诱导的心脏毒性价值最佳,AUC为0.767,敏感度100%,特异度52%。
临床应用与阅片要点
- T2 mapping可最早于第2周检出早期蒽环类药物诱导的心脏毒性,阅片时关注左心室第7、11、12节段T2值。
- T2* mapping可作为T2 mapping的补充评估心脏毒性,并作为检出化疗早期铁变化的有效指标。
- 联合T2* mapping可一站式评估肝毒性和补充心脏毒性,室间隔中部与肝脏T2*值正相关提示肝脏和心脏铁含量随化疗药物增加而增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the early prevalence of anthracycline-induced cardiotoxicity (AIC) and anthracycline-induced liver injury (AILI) using T2 and T2* mapping and to explore their correlations.
MATERIALS AND METHODS: The study included 17 cardiotoxic rabbits that received weekly injections of doxorubicin and magnetic resonance imaging (MRI) every 2 weeks for 10 weeks. Cardiac function and T2 and T2* values were measured on each period. Histopathological examinations for two to five rabbits were performed after each MRI scan. The earliest sensitive time and the threshold of MRI parameters for detecting AIC and AILI based on these MRI parameters were obtained. Moreover, the relationship between myocardial and liver damage was assessed.
RESULTS: Early AIC could be detected by T2 mapping as early as the second week and focused on the 7th, 11th, and 12th segments of left ventricle. The cutoff value of 46.64 for the 7th segment had the best diagnostic value, with an area under the curve (of 0.767, sensitivity of 100%, and specificity of 52%. T2* mapping could detect the change in iron content for early AIC at the middle interventricular septum and AILI as early as the sixth week (p = 0.014, p = 0.027). The T2* values of the middle interventricular septum showed a significant positive association with the T2* values of the liver (r = 0.39, p = 0.002).
CONCLUSION: T2 and T2* mapping showed value one-stop assessment of AIC and AILI and could obtain the earliest MRI diagnosis point and optimal parameter thresholds for these conditions.
CLINICAL RELEVANCE STATEMENT: Anthracycline-induced cardiotoxicity could be detected by T2 mapping as earlier as the second week, mainly focusing on the 7th, 11th, and 12th segments of left ventricle. Combined with T2* mapping, hepatoxicity and supplementary cardiotoxicity were assessed by one-stop scan.
KEY POINTS: • MRI screening time of cardiotoxicity was as early as the second week with focusing on T2 values of the 7th, 11th, and 12th segments of left ventricle. • T2* mapping could be used as a complement to T2 mapping to evaluate cardiotoxicity and as an effective index to detect iron change in the early stages of chemotherapy. • The T2* values of the middle interventricular septum showed a significant positive association with the T2* values of the liver, indicating that iron content in the liver and heart increased with an increase in the chemotherapeutic drugs.
引用
- Feng XL, Qi WY, Xiao ZY, et al. Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models. Eur Radiol. 2023. PMID: 37552260. doi:10.1007/s00330-023-10027-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。